Syner-G Biopharma Group Appoints Ron Kraus as CEO

Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

Syner-G BioPharma Group announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Kraus has more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

Prior to joining Syner-G, Kraus was Chief Operating Officer at Cytel. He succeeds Syner-G’s founder, Prabu Nambiar, PhD, MBA, RAC, as CEO.

Read more about Kraus' appointment here.